Cross-sectional study reports plateauing antiretroviral therapy coverage among pregnant women with human immunodeficiency virus, highlighting challenges in preventing vertical transmission.
Background Globally, the rate of antiretroviral therapy coverage for pregnant women living with human immunodeficiency virus (HIV) increased by 38% between 2010 and 2015 but only by 2% between 2016 and 2020.
No takes yet. Share an insight, caveat, or question.
Torokaa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: